Randomised, double blind, placebo controlled, multicentre Study comparing Ciprofoxacin DPI 32.5mg BID intermittently administered for 28 days on /28days off 14 days on /14 days off versus placebo to e

Project: Research

Project Details

StatusFinished
Effective start/end date1/10/131/05/14